IBT Bioservices
- Company typePrivate
- Founded2010
- HeadquartersRockville, United States
- Headcount11–50
- GTM typeB2B
- OfferingServices
IBT Bioservices firmographics
Firmographics- Name
- IBT Bioservices
- Legal name
- Integrated Biotherapeutics, Inc.
- Website
- https://ibtbioservices.com
- Company type
- Private
- Founded year
- 2010
- Operating status
- Operating
- Headcount range
- 11–50 employees
- Ownership category
- akta.pro rank
IBT Bioservices industry classification
Industry- Product category
- Preclinical Contract Research Services
- NAICS
- Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151)
- SIC
- Services-Commercial Physical & Biological Research (8731), Services-Testing Laboratories (8734), In Vitro & In Vivo Diagnostic Substances (2835)
- akta.pro primary industry
- Clinical CROs (Phase I–IV) (HLAGAAAA)
- akta.pro secondary industries
- Central Laboratory & Clinical Trial Testing CROs (HLAGAAAE), Specialty Therapeutic-Area CROs (e.g., oncology/rare disease) (HLAGAAAL), Bioanalytical & Biomarker CROs (PK/PD/Immunogenicity) (HLAGAAAD)
Keywords
Where IBT Bioservices is headquartered
LocationHeadquarters
- HQ city
- Rockville
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
IBT Bioservices business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Revenue model
- CRO Services Revenue: Preclinical and clinical research services including in vitro assays, animal studies, GxP testing, custom assay development, and concierge services. Revenue generated through project-based contracts and service agreements with biotech, pharma, and government clients.
- Reagent Product Sales: Sale of research reagents including recombinant proteins, antibodies, pseudoviruses, ELISA kits, and cell lines through e-commerce storefront and distribution partners.
- Grant Support Services: Technical consulting and support services for SBIR, NIH, NIAID, BARDA, and DOD grant applications. The team has supported clients in securing over $150M in cumulative grant funding.
Pricing tiers
| Model | Billing | Price |
|---|---|---|
| Unit Pricing | Pay-as-you-go | Individual reagent products priced per unit |
Go-to-market motion2 records
Distribution channels3 records
Marketing channels4 records
IBT Bioservices product offering
Product offeringCore offering
IBT Bioservices is a full-service clinical and preclinical Contract Research Organization (CRO) providing research services and biological reagents for vaccine and therapeutic development. The company delivers in vitro assays, animal models, GxP-compliant testing, and concierge program management targeting infectious disease pathogens including filoviruses, flaviviruses, and Staphylococcus aureus. It also manufactures and sells recombinant proteins, antibodies, pseudoviruses, ELISA kits, and cell lines through its e-commerce storefront and distribution partners.
Product overview
IBT Bioservices is a Full Service Clinical & Preclinical Contract Research Organization (CRO) offering a comprehensive portfolio of biological reagents and research services for vaccine and therapeutic development. The company's product portfolio includes Recombinant Proteins, Primary Antibodies, Pseudovirus, Virus Like Particles, ELISA Kits, Vaccine Adjuvants, and Cell Lines targeting viral pathogens (filoviruses including Ebola, Marburg, Sudan, Bundibugyo; flaviviruses; influenza; coronaviruses) and bacterial pathogens (Staphylococcus aureus, C. difficile, C. perfringens). Services span in vitro assays (antiviral, bacterial, ELISA, Luminex, flow cytometry, qPCR), animal models (rodent and NHP), GxP compliant testing, pharmacokinetics/biodistribution, concierge program management, and custom assay development. The company operates from Rockville, MD with distribution partners including Thomas Scientific, Abcam, VWR, Fisher Scientific, and international distributors.
Differentiator
Problem solved
Functional benefit
Quantifiable outcome
- 120+ clients supported for grant applications with $150M+ cumulative funding secured
- +2 more outcomes
Companies that use IBT Bioservices
Customer profileNamed customers2 records
Segments4 records
Ideal customer profiles4 records
IBT Bioservices technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature4 records
IBT Bioservices partnerships and signals
Strategic signalPartnerships
Seven partnerships are on record, tiered core and minor.
- Dyadic InternationalcoreOEM distribution agreement with IBT Bioservices. Dyadic's C1 protein production platform products are distributed through IBT. Multiple commercial product launches with IBT including recombinant DNase I and transferrin for research applications.
- Dyadic International / Dyadic Applied BioSolutionscoreDyadic Applied BioSolutions announced a commercial distribution partnership with IBT Bioservices, through which Dyadic's recombinant protein products will be marketed via IBT's sales channels. Initial products include recombinant DNase I and transferrin, mainly for research applications. This partnership expands IBT's product portfolio and market reach.
- Thomas ScientificminorDistribution partner for IBT products in the USA
- AbcamminorDistribution partner for IBT products in Europe and USA
- VWRminorDistribution partner for IBT products
- Fisher ScientificminorDistribution partner for IBT products
- Clementia BiotechminorDistribution partner for IBT products in India and Asia
Scale indicators5 records
Recent moves2 records
IBT Bioservices competitors and assessment
Company assessmentBroad incumbents
- BioReliance (Merck KGaA / Sigma-Aldrich): Provides biopharmaceutical testing services including viral clearance, biosafety, and biologics characterization. Comparable to IBT's GxP-compliant testing offerings as part of a much larger testing services portfolio.
- Charles River Laboratories: Large public CRO offering preclinical and clinical research services including biologics safety, immunology, and infectious disease models. A broad incumbent with overlapping capabilities but IBT's infectious disease focus is more specialized.
- WuXi AppTec: Global CRO/CDMO providing preclinical and clinical research services across many therapeutic areas. Overlaps with IBT on biologics testing and assay services at much larger scale and broader scope.
- IQVIA (Q² Solutions): Large clinical trial laboratory services provider offering central lab, bioanalytical, and biomarker testing for clinical trials. Comparable to IBT's clinical trial testing services (Luminex cytokine analysis) at much greater scale.
Direct peers
- Southern Research: Nonprofit CRO providing preclinical infectious disease research, antiviral/antibacterial screening, and BSL-2/BSL-3 capabilities. Comparable in government-funded infectious disease CRO services and specialized assay work.
- Lovelace Biomedical & Environmental Research Institute: Preclinical CRO offering in vivo efficacy models, infectious disease and biodefense research, and GLP-compliant studies. Overlaps directly with IBT's animal model and GxP services for government and biopharma clients.
- hVIVO: Specialist infectious disease CRO focused on virology, antiviral, and respiratory challenge studies (flu, RSV, SARS-CoV-2). Directly comparable to IBT in infectious disease preclinical/clinical research services and reagent offerings.
- Battelle Memorial Institute: Contract research organization performing infectious disease research, biosafety testing, and government-funded biodefense studies. Comparable to IBT's work for NIAID, NIH, DOD, and BARDA.
- SRI International (Biosciences Division): Contract research organization with immunology, infectious disease, and assay development capabilities. Provides comparable preclinical research services and government grant-supported programs.
- ImQuest BioSciences: Small infectious disease-focused CRO providing in vitro and in vivo efficacy testing, antiviral/antibacterial assays, and preclinical development services. Comparable niche specialty and customer base to IBT.
Market position
Strengths5 records
Weaknesses5 records
Key risks5 records
Key highlights7 records
Customer concentration
IBT Bioservices social profiles
Digital presenceIBT Bioservices compliance and trust
Trust signalCompliance2 records
IBT Bioservices financial estimates
Financial estimateRevenue estimate
Valuation estimate
IBT Bioservices leadership team
Management profileNumber of profiles
Profiles3 records
IBT Bioservices subsidiaries and ownership
Company hierarchySubsidiaries1 record
IBT Bioservices funding detail
Funding detailFunding overview
Funding rounds1 record
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
IBT Bioservices M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about IBT Bioservices
What does IBT Bioservices do?
IBT Bioservices is a full-service clinical and preclinical Contract Research Organization (CRO) providing research services and biological reagents for vaccine and therapeutic development. The company delivers in vitro assays, animal models, GxP-compliant testing, and concierge program management targeting infectious disease pathogens including filoviruses, flaviviruses, and Staphylococcus aureus. It also manufactures and sells recombinant proteins, antibodies, pseudoviruses, ELISA kits, and cell lines through its e-commerce storefront and distribution partners.
Is IBT Bioservices a public or private company?
IBT Bioservices is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was IBT Bioservices founded?
IBT Bioservices was founded in 2010. It employs 11 to 50 people.
Where is IBT Bioservices based?
IBT Bioservices is headquartered in Rockville, United States, in the North America region.
How does IBT Bioservices make money?
Three revenue lines are on record. CRO Services Revenue is the primary driver. The others are reagent Product Sales and grant Support Services.
Who are IBT Bioservices's main competitors?
Broad incumbents on record are BioReliance (Merck KGaA / Sigma-Aldrich), Charles River Laboratories, WuXi AppTec and IQVIA (Q² Solutions). Direct peers are Southern Research, Lovelace Biomedical & Environmental Research Institute, hVIVO, Battelle Memorial Institute, SRI International (Biosciences Division) and ImQuest BioSciences.
Does IBT Bioservices have an API?
No public API is recorded for IBT Bioservices.
What industry is IBT Bioservices in?
IBT Bioservices's product category is Preclinical Contract Research Services. Its primary akta.pro industry code is HLAGAAAA, Clinical CROs (Phase I–IV), with a secondary code of HLAGAAAE, Central Laboratory & Clinical Trial Testing CROs. Its NAICS code is 621511 and its SIC code is 8731.